Mr Mrs Miss Ms Dr Other

Dr
Aron
Ferenczi

Trainee Patent Attorney

Glasgow Office Edinburgh Office

Life sciences

Telephone. +44(0) 141 229 5800
Email. aferenczi@hgf.com

Experience

Aron holds a PhD in molecular and cellular biology and works on a diverse range of largely nucleotide, peptide and cell-based technologies. He has in-depth knowledge of plants and algae, gene editing and DNA repair, with a professional interest in these areas as well as food and drink technologies. He is involved in the Food Technology, Agritech and Gene Editing sector specialisms within the Life Sciences group.

His patent practice draws on six years of research experience, during which he developed a novel gene-editing technique and studied the DNA repair pathways involved in the model green alga Chlamydomonas reinhardtii. He is also experienced in plant-based transient gene expression. His research findings have been published in high-impact journals including Nature Communications and PNAS. During and after his PhD, he worked at a startup specialising in the microalgae-based food industry.

Aron graduated from The University of Edinburgh with an honours degree in Biological Sciences specialising in Plant Science. He completed an undergraduate internship in wheat genetics at the John Innes Centre. He has a Master’s degree in Bioinformatics and a PhD from the same university. He joined HGF in 2023.

Qualifications

Trainee


BSC

(Hons) Biological Sciences (Plant Science)

MSC

Bioinformatics

PHD

Cell and Molecular Biology

Publications

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

View publication online

The Bite of Implied Consent: Lessons from the Pink Lady Case

View publication online

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

View publication online

IP Ingredients: Can you patent a flavour?

View publication online

Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii

View publication online

Download publication PDF

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Antibody Series #2 Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.